KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orasure Technologies (OSUR) Equity Ratio (2010 - 2025)

Orasure Technologies recorded quarterly Equity Ratio of 0.85 in Q4 2025, down 1.19% quarter-over-quarter from 0.86 in Q3 2025, and down 1.18% year-over-year from 0.86 in Q4 2024.

Orasure Technologies' Equity Ratio history runs 16 years deep, the most recent figure standing at 0.85 for Q4 2025.

  • In Q4 2025, Equity Ratio fell 1.18% year-over-year to 0.85; the TTM figure through Dec 2025 stood at 0.85 (down 1.18% YoY), while the FY2025 annual figure was 0.85, down 1.18% from the prior year.
  • Equity Ratio came in at 0.85 for Q4 2025 at Orasure Technologies, down from 0.86 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.92 in Q3 2024 to a low of 0.79 in Q3 2022.
  • A 5-year average of 0.86 and a median of 0.86 in 2023 frame the typical range for Equity Ratio.
  • Across the five-year window, Equity Ratio decreased 7.82% in 2022 and gained 11.47% in 2023, its largest moves.
  • Orasure Technologies' Equity Ratio stood at 0.83 in 2021, then decreased by 0.61% to 0.82 in 2022, then increased by 8.71% to 0.89 in 2023, then fell by 4.09% to 0.86 in 2024, then dropped by 1.18% to 0.85 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods registered 0.85, 0.86, and 0.86 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.88
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.47
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.73
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.35
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.67
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.66
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.30
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.52
10 Orasure Technologies 231.23 Mn 31.96 Mn - 0.85

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.85
Sep 30, 2025 0.86
Jun 30, 2025 0.86
Mar 31, 2025 0.87
Dec 31, 2024 0.86
Sep 30, 2024 0.92
Jun 30, 2024 0.91
Mar 31, 2024 0.91
Dec 31, 2023 0.89
Sep 30, 2023 0.88
Jun 30, 2023 0.87
Mar 31, 2023 0.86
Dec 31, 2022 0.82
Sep 30, 2022 0.79
Jun 30, 2022 0.80
Mar 31, 2022 0.84
Dec 31, 2021 0.83
Sep 30, 2021 0.85
Jun 30, 2021 0.87
Mar 31, 2021 0.88
Dec 31, 2020 0.88
Sep 30, 2020 0.89
Jun 30, 2020 0.91
Mar 31, 2020 0.89
Dec 31, 2019 0.88
Sep 30, 2019 0.89
Jun 30, 2019 0.88
Mar 31, 2019 0.88
Dec 31, 2018 0.90
Sep 30, 2018 0.91
Jun 30, 2018 0.91
Mar 31, 2018 0.90
Dec 31, 2017 0.87
Sep 30, 2017 0.88
Jun 30, 2017 0.89
Mar 31, 2017 0.90
Dec 31, 2016 0.89
Sep 30, 2016 0.87
Jun 30, 2016 0.84
Mar 31, 2016 0.86
Dec 31, 2015 0.84
Sep 30, 2015 0.83
Jun 30, 2015 0.89
Mar 31, 2015 0.88
Dec 31, 2014 0.84
Sep 30, 2014 0.84
Jun 30, 2014 0.89
Mar 31, 2014 0.89
Dec 31, 2013 0.87
Sep 30, 2013 0.87
Jun 30, 2013 0.89
Dec 31, 2012 0.89
Mar 31, 2012 0.80
Dec 31, 2011 0.78
Sep 30, 2011 0.78
Jun 30, 2011 0.83
Dec 31, 2010 0.84